Cláudia A. Valente

Dr. Cláudia A. Valente


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2019 in Science Immunology
Verified
Journal Article
Open access
PDF file
MRMiguel Ribeiro
Miguel Ribeiro
HBHelena C. Brigas
Helena C. Brigas
MTMariana Temido-Ferreira
Mariana Temido-Ferreira
PPPaula A. Pousinha
Paula A. Pousinha
TRTommy Regen
Tommy Regen
JRJulie C. Ribot
Julie C. Ribot
Meningeal γδ T cells are biased toward IL-17 production and control hippocampal synaptic plasticity and short-term memory.

28 September 2021 in Journal of Alzheimer’s Disease
Verified
Journal Article
Open access
PDF file
MZMariana Van Zeller
Mariana Van Zeller
DDDiogo M. Dias
Diogo M. Dias
ASAna M. Sebastião
Ana M. Sebastião
CVCláudia A. Valente
Cláudia A. Valente
Alzheimer’s disease (AD) is the most prevalent neurodegenerative disease commonly diagnosed among the elderly population. AD is characterized by the loss of synaptic connections, neuronal death, and progressive cognitive impairment, attributed to the extracellular accumulation of senile plaques, composed by insoluble aggregates of amyloid-β (Aβ) peptides, and to the intraneuronal formation of neurofibrillary tangles shaped by hyperphosphorylated filaments of the microtubule-associated protein tau. However, evidence showed that chronic inflammatory responses, with long-lasting exacerbated release of proinflammatory cytokines by reactive glial cells, contribute to the pathophysiology of the disease. NLRP3 inflammasome (NLRP3), a cytosolic multiprotein complex sensor of a wide range of stimuli, was implicated in multiple neurological diseases, including AD. Herein, we review the most recent findings regarding the involvement of NLRP3 in the pathogenesis of AD. We address the mechanisms of NLRP3 priming and activation in glial cells by Aβ species and the potential role of neurofibrillary tangles and extracellular vesicles in disease progression. Neuronal death by NLRP3-mediated pyroptosis, driven by the interneuronal tau propagation, is also discussed. We present considerable evidence to claim that NLRP3 inhibition, is undoubtfully a potential therapeutic strategy for AD.

23 May 2014 in Cerebral Cortex
Verified
Journal Article
Open access
PDF file
AJAndré Jerónimo-Santos
André Jerónimo-Santos
SVSandra H. Vaz
Sandra H. Vaz
SPSara Parreira
Sara Parreira
SRSofia Rapaz-Lérias
Sofia Rapaz-Lérias
ACAntónio P. Caetano
António P. Caetano
MDMaria José Diógenes
Maria José Diógenes
Brain-derived neurotrophic factor (BDNF) and its high-affinity full-length (FL) receptor, TrkB-FL, play a central role in the nervous system by providing trophic support to neurons and regulating synaptic plasticity and memory. TrkB and BDNF signaling are impaired in Alzheimer's disease (AD), a neurodegenerative disease involving accumulation of amyloid-β (Aβ) peptide. We recently showed that Aβ leads to a decrease of TrkB-FL receptor and to an increase of truncated TrkB receptors by an unknown mechanism. In the present study, we found that (1) Aβ selectively increases mRNA levels for the truncated TrkB isoforms without affecting TrkB-FL mRNA levels, (2) Aβ induces a calpain-mediated cleavage on TrkB-FL receptors, downstream of Shc-binding site, originating a new truncated TrkB receptor (TrkB-T′) and an intracellular fragment (TrkB-ICD), which is also detected in postmortem human brain samples, (3) Aβ impairs BDNF function in a calpain-dependent way, as assessed by the inability of BDNF to modulate neurotransmitter (GABA and glutamate) release from hippocampal nerve terminals, and long-term potentiation in hippocampal slices. It is concluded that Aβ-induced calpain activation leads to TrkB cleavage and impairment of BDNF neuromodulatory actions.

21 July 2015 in Glia
Verified
Journal Article
Closed access
PDF file
RARita I. Aroeira
Rita I. Aroeira
ASAna M. Sebastião
Ana M. Sebastião
CVCláudia A. Valente
Cláudia A. Valente

1 March 2011 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
RARita I. Aroeira
Rita I. Aroeira
JRJoaquim A. Ribeiro
Joaquim A. Ribeiro
ASAna M. Sebastião
Ana M. Sebastião
CVCláudia A. Valente
Cláudia A. Valente

11 July 2018 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
DMDaniela M. Magalhães
Daniela M. Magalhães
NPNoémia Pereira
Noémia Pereira
DRDiogo M. Rombo
Diogo M. Rombo
CBCláudia Beltrão-Cavacas
Cláudia Beltrão-Cavacas
ASAna M. Sebastião
Ana M. Sebastião
CVCláudia A. Valente
Cláudia A. Valente
Epilepsy is a prevalent neurological disorder worldwide. It is characterized by an enduring predisposition to generate seizures and its development is accompanied by alterations in many cellular processes. Organotypic slice cultures represent a multicellular environment with the potential to assess biological mechanisms, and they are used as a starting point for refining molecules for in vivo studies. Here, we investigated organotypic slice cultures as a model of epilepsy. We assessed, by electrophysiological recordings, the spontaneous activity of organotypic slices maintained under different culture protocols. Moreover, we evaluated, through molecular-based approaches, neurogenesis, neuronal death, gliosis, expression of proinflammatory cytokines, and activation of NLRP3 inflammasome (nucleotide-binding, leucine-rich repeat, pyrin domain) as biomarkers of neuroinflammation. We demonstrated that organotypic slices, maintained under a serum deprivation culture protocol, develop epileptic-like activity. Furthermore, throughout a comparative study with slices that do not depict any epileptiform activity, slices with epileptiform activity were found to display significant differences in terms of inflammation-related features, such as (1) increased neuronal death, with higher incidence in CA1 pyramidal neurons of the hippocampus; (2) activation of astrocytes and microglia, assessed through western blot and immunohistochemistry; (3) upregulation of proinflammatory cytokines, specifically interleukin-1β (IL-1β), interleukin-6, and tumor necrosis factor α, revealed by qPCR; and (4) enhanced expression of NLRP3, assessed by western blot, together with increased NLRP3 activation, showed by IL-1β quantification. Thus, organotypic slice cultures gradually deprived of serum mimic the epileptic-like activity, as well as the inflammatory events associated with in vivo epilepsy. This system can be considered a new tool to explore the interplay between neuroinflammation and epilepsy and to screen potential drug candidates, within the inflammatory cascades, to reduce/halt epileptogenesis.